Description

With 40+ years of combined experience in mass spectrometry, Cayman scientists are available to support your biomarker and drug development studies. Equipped with state-of-the-art instrumentation, we are continuously expanding our LC-MS/MS capabilities for the detection and quantification of drugs, metabolites, and biomarkers in biological samples and utilize rigorous and modern scientific methods to provide our customers with the highest quality data. Our team of experts can help develop fit-for-purpose methods for discovery, pharmacokinetics, and formulation applications.

Cayman’s mass spectrometry-based analytical services can be utilized at various stages of the drug discovery process:

• Biomarker Discovery: Lipidomics, proteomics, and targeted disease pathway studies
• Drug Property Screening: High-throughput solubility, log D, and aqueous stability studies
• Analytical Support for:
• Dosing, formulation, and drug release
• Drug metabolism (e.g., liver microsome stability and metabolic fate studies)
• Pharmacokinetics (PK): Method development and analysis of drugs from high-throughput PK screening of early-phase drug candidates or plasma and tissue drug distribution and clearance studies

Item	Analytical Chemistry Services
Company	Cayman Chemical
Price	Get QuoteGet Quote
Catalog Number	Custom